Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Potash Corp of Sakatchewan Inc.’s ( POT - Analyst Report ) fourth-quarter 2012 adjusted earnings (excluding a provision for settlement of antitrust claims) of 52 cents per share missed the Zacks Consensus Estimate of 59 cents. Earnings, as reported, fell to 48 cents per share from 78 cents per share a recorded a year ago.
For full-year 2012, adjusted earnings were $2.80 per share, missing the Zacks Consensus Estimate of $2.99. Reported earnings were $2.37 per share, down from $3.51 per share in 2011.
Sales came in at $1,642 million in the quarter, down 12% from $1,865 million registered a year ago, missing Zacks Consensus Estimate of $1,853 million. The year-over-year decline was due to reduced contributions from all three nutrients arising from slack global fertilizer markets and lower demand.
For full year, sales dipped 9% to $7,927 million and missed the Zacks Consensus Estimate of $8,088 million.
Segment Review
Potash: Sales volumes of 1.3 million tons in the reported quarter were down from 1.6 million tons in the year-ago quarter. Demand for potash remained strong in North America and drove sales but were offset by lower offshore sales volumes. Shipments to offshore customers decreased on a year-over-year basis. This coupled with lower realized prices led to a decline in gross margin. Gross margin declined 42.2% year over year to $281 million.
Average realized potash price was $387 per ton, down 10.2% from the prior-year quarter.
Phosphate: Sales volumes declined 5.8% year over year to 0.8 million tons, due to lower production as a result of challenging mining conditions at the company’s Aurora mine. Average realized phosphate price was $577 per ton, down 8.6% year over year on lower solid and liquid fertilizer prices due to weak demand. Gross margin went down 39.3% to $99 million.
Nitrogen: Sales volumes for the segment decreased 1.3% to 1.1 million tons due to gas interruptions in Trinidad. Gross margin decreased 14.5% to $206 million in the reported quarter. Average realized prices for nitrogen products decreased 1.7% to $453 per ton.
Financial Condition
Cash and cash equivalents amounted to $562 million as of Dec 31, 2012, versus $430 million as of Dec 31, 2011. Long-term debt was $3,466 million versus $3,705 million a year ago. Capital expenditure for the fourth quarter amounted to $628 million while operating cash flow came in at $872 million.
Outlook
The company expects earnings for the first quarter and full-year 2013 in the range of 50 cents to 65 cents per share and $2.75 to $3.25 per share, respectively.
The company expects gross profits from its potash business in the range of $1.9 billion to $2.4 billion in 2013. It expects shipments in the range of 8.5-9.2 million tons. The combined phosphate and nitrogen gross margin for full-year 2013 has been forecasted in the range of $1.5 billion to $1.7 billion.
Capital expenditures for the year are anticipated to be about $1.5 billion, with a significant portion related to the remaining potash expansion projects at New Brunswick and Rocanville.
Potash Corp. currently retains a Zacks Rank #4 (Sell).
Other companies having a favorable Zacks Rank in the fertilizer industry are Agrium Inc. ( AGU - Analyst Report ) , Rentech Nitrogen Partners, L.P. ( RNF - Snapshot Report ) and Yara International ASA ( YARIY ) . All these stocks carry a Zacks Rank #2 (Buy).
Read the full reports :
Analyst Report on POT
Analyst Report on AGU
Snapshot Report on RNF
on YARIY